AI Summary
We reviewed 39 live results for tnf inhibitors and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Tnf Inhibitors.
Comparison Table
Recommended
Hulio
Source: Viatris / Fujifilm Kyowa Kirin Biologics
Description
Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis.
Best for
immune-mediated disorders, Singapore NDF access and subcutaneous administration
View Details
Rating
Abrilada
Source: Pfizer Private Limited
Description
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Best for
biologic therapy, chronic inflammation management and subcutaneous injection
View Details
Rating
Hadlima
Source: Samsung Bioepis / Organon
Description
Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada.
Best for
US healthcare market, Australian pharmaceutical access and Canadian healthcare patients
View Details
Rating
| Compare | Hulio | Abrilada | Hadlima |
|---|---|---|---|
| Source | Viatris / Fujifilm Kyowa Kirin Biologics | Pfizer Private Limited | Samsung Bioepis / Organon |
| Description | Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis. | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada. |
| Best for | immune-mediated disorders, Singapore NDF access and subcutaneous administration | biologic therapy, chronic inflammation management and subcutaneous injection | US healthcare market, Australian pharmaceutical access and Canadian healthcare patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Hulio from Viatris / Fujifilm Kyowa Kirin Biologics."
I picked this because A formulary-listed biosimilar providing a standard dosage option in Singapore.
Share this search
Related Finds